z-logo
open-access-imgOpen Access
Utilization of Filgrastim and Infliximab Biosimilar Products in Medicare Part D, 2015-2019
Author(s) -
S. M. Qasim Hussaini,
Arjun Gupta,
Kelly E. Anderson,
Jeromie Ballreich,
Lauren Hersch Nicholas,
G. Caleb Alexander
Publication year - 2022
Publication title -
jama network open
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.278
H-Index - 39
ISSN - 2574-3805
DOI - 10.1001/jamanetworkopen.2022.1117
Subject(s) - biosimilar , infliximab , filgrastim , medicine , business , tumor necrosis factor alpha , granulocyte colony stimulating factor , chemotherapy

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom